Cerebrovascular Registry

Cerebrovascular Disorders Clinical Trial

Official title: Prove/Cerebrovascular Registry

Status Active, not recruiting

Clinical Trial Summary

Patients with stroke were registered based on the WHO/ MONICA protocol and were followed-up for 28 days, starting in 2015 in PROVE Registry

Clinical Trial Description

PROVE program started in 2015, the registration of stroke continued but followed the WHO Stepwise method instead of WHO/MONICA .Patients are followed up for two years. The corresponding questionnaire covered the patients' demographic data, medical history upon hospital admission, history of comorbidities, medications used prior to the treatment, history of drug abuse, heart and brain imaging, history of blood tests and blood diseases, hospital treatments received, hospitalization complications, medications prescribed at the time of discharge, discharge status and the definite diagnosis of type of stroke according to CT or MRI.

The patients were followed-up over the phone or in person from the 1st, 3rd and 12th months to two years. The patients' disabilities were measured using the Barthel Index and the Modified Rankin Scale (MRS). The reliability and validity of these two questionnaires have already been investigated in Persian. In addition, secondary prevention measures, rehabilitation status and the incidence of new cardiovascular events were also examined in the follow-up. The stroke registration personnel received an initial training of three two-hour sessions and monthly one-hour retraining sessions. They visited the archives of various hospitals on a daily basis and registered the data contained in the records ;

Related Conditions & MeSH terms

• Cerebrovascular Disorders

• NCT number: NCT03211091
• Study type: Observational [Patient Registry]
• Source: Isfahan University of Medical Sciences
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 1, 2015
• Completion date: January 1, 2020